Delivery Order SPE2DB24D2205-SPE2DB25FEFSP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12.5K to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is a combination antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency Medical Supply...
- The Defense Logistics Agency awarded a $6,519.84 delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with an ultimate completion date of July 25, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under a larger federal contract vehicle. This award falls under AmerisourceBergen's significant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $4,166.96 and an ultimate completion date of August 1, 2025. The contract does not utilize a set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) valued at $6,519.84 under a Firm Fixed Price contract type. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location and serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a Delivery Order valued at $7,320.36 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This firm fixed price, non-set-aside contract was awarded on July 28, 2025, with an ultimate completion date of July 29, 2025. TRIUMEQ is an HIV treatment medication combining dolutegravir, abacavir, and lamivudine, reflecting the military and veteran healthcare system's need for critical antiretroviral therapies....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This firm fixed-price delivery order carries a ceiling value of $27,001.31 and is scheduled for completion by August 1, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is an...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for TRIUMEQ 600-50-300 MG TABLET, which are likely antiretroviral medications used in the treatment of HIV/AIDS. The $6,389.46 firm fixed-price contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency awarded a $12,444.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for TRIUMEQ 600-50-300 MG tablets. Under this order, Amerisourcebergen will deliver 30 bottles of the HIV treatment medication to a facility in Conshohocken, Pennsylvania by September 11, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen frequently supports the Defense Logistics Agency in fulfilling prescription...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation, for the provision of TRIUMEQ 600-50-300 MG tablets. The $15,507.76 contract has an ultimate completion date of November 18, 2021. AmerisourceBergen Drug Corp serves as the prime contractor on this delivery order, which is issued under an indefinite delivery contract (IDC) with a potential ceiling...
- The Defense Logistics Agency Troop Support Medical awarded a $28,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4,562,102,751 Triumeq tablets. Amerisourcebergen will deliver the HIV/AIDS medication to its facility in Conshohocken, Pennsylvania by September 11th, 2023, fulfilling requirements under an indefinite-delivery/indefinite-quantity contract vehicle. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFSPDelivery Order
The Defense Logistics Agency awarded a $11,096.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with a completion date of August 4, 2025. This competitively awarded, non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is a combination antiretroviral medication used to treat HIV infection, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement to support military and veteran healthcare systems. AmerisourceBergen's prime vendor contract with DLA enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support Defense Health Agency operations and other federal healthcare customers. This delivery order exemplifies the routine pharmaceutical fulfillment occurring under the larger IDC vehicle, which provides the government with flexible access to critical medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 8/1/25 |